Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial

scientific article published on February 2014

Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/INF.0000000000000023
P698PubMed publication ID23989106
P5875ResearchGate publication ID256290235

P50authorNoga Givon-LaviQ47460873
Ron DaganQ92965709
P2093author name stringDavid Greenberg
Yair Sadaka
Noga Givon-Lavi
Jacob Bar-Ziv
Shalom Ben-Shimol
P433issue2
P921main subjectplaceboQ269829
alveolar pneumoniaQ11611666
pneumoniaQ12192
P304page(s)136-142
P577publication date2014-02-01
P1433published inPediatric Infectious Disease JournalQ15756717
P1476titleShort-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial
P478volume33

Reverse relations

cites work (P2860)
Q38867802A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
Q38628311An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence
Q89945831Antibiotic Prescribing Patterns for Acute Otitis Media for Children 2 Years and Older
Q90370905Antibiotic Use and Outcomes in Children in the Emergency Department With Suspected Pneumonia
Q42339223Antibiotics in childhood pneumonia: how long is long enough?
Q57153846Antimicrobial Therapy in Community-Acquired Pneumonia in Children
Q33642866Antimicrobial stewardship in daily practice: Managing an important resource
Q85911781Antimicrobial stewardship in daily practice: Managing an important resource
Q94587430Characterization of children younger than 5 Years of age with severe community-acquired alveolar pneumonia (CAAP) requiring Pediatric Intensive Care Unit (PICU) admission
Q40041892Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies.
Q90096269Community-acquired pneumonia among children: the latest evidence for an updated management
Q36070209Comparative Effectiveness of Beta-lactam Versus Macrolide Monotherapy in Children with Pneumonia Diagnosed in the Outpatient Setting
Q33792393Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines
Q33678141Discovery and validation of biomarkers to guide clinical management of pneumonia in African children
Q64899765Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
Q64092119HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial
Q37220711Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Q55619166La gestion des antimicrobiens dans la pratique quotidienne : administrer une ressource importante.
Q46486735La pneumonie non compliquée chez les enfants et les adolescents canadiens en santé : points de pratique sur la prise en charge
Q38767450Recent Developments in Pediatric Community-Acquired Pneumonia.
Q47547063Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial
Q24187150Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months
Q41986988Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.
Q36425466Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.
Q40488754Variation in paediatric hospital antibiotic guidelines in Europe.

Search more.